Company news

Imagion Biosystems Ltd. news in 2025

Imagion Biosystems Ltd.'s news releases, calls and decks from 2025, newest first.

View company

Positive Final WSU Trial Results To Support IND Submission

December 1, 2025

Positive Results Received from WSU on MagSense Dosage

November 4, 2025

Appendix 4C and Quarterly Activities Report - September 2025

October 20, 2025

Imagion Biosystems HER2 Breast Cancer Program Update

October 6, 2025

Ph2 Manufacturing & Imaging Optimisation Activities Commence

September 7, 2025

Appendix 4D and Half-yearly Financial Report

August 27, 2025

IBX Secures Firm Commitments for A$3.5m Capital Raising

August 3, 2025

Trading Halt

July 30, 2025

Appendix 4C and Quarterly Activities Report - June 2025

July 28, 2025

Imagion MagSense Breast Cancer Program Phase 2 Trial Update

July 14, 2025

Imagion Receive Positive FDA Feedback for HER2 Phase 2 Trial

July 9, 2025

Appendix 4C and Quarterly Activities Report - March 2025

April 30, 2025

Appendix 4E and 2024 Financial Report

February 28, 2025

Imagion Initiates Manufacturing of Drug for Phase 2 Study

February 18, 2025

Quarterly Activities/Appendix 4C Cash Flow Report

January 29, 2025

Decks in 2025